secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2023-10-20T23:59:59+00:00
Accession:  0001387131-23-012492
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals receives Nasdaq minimum bid price deficiency notice
-------------------------------------------------------------------------

- Oct 17, 2023: Nasdaq notified Tonix that its common stock no longer meets the $1 minimum bid price requirement.
- Company has 180 calendar days, until April 15, 2024, to regain compliance by closing at $1+ for 10 consecutive days.
- If not cured, Tonix may seek an additional 180-day period if it meets other listing standards and intends to effect a reverse stock split.
- Failure to regain compliance could result in delisting from the Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000138713123012492/0001387131-23-012492-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000138713123012492/tnxp-8k_101723.htm
  HTML page:      https://secwatch.observer/filing/0001387131-23-012492

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer